鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/10 | 3,720 | 3,750 | 3,700 | 3,730 | +30 | +0.8% | 18,100 |
| 2024/06/07 | 3,685 | 3,705 | 3,665 | 3,700 | +5 | +0.1% | 13,300 |
| 2024/06/06 | 3,750 | 3,750 | 3,695 | 3,695 | -70 | -1.9% | 11,200 |
| 2024/06/05 | 3,800 | 3,830 | 3,745 | 3,765 | -35 | -0.9% | 17,400 |
| 2024/06/04 | 3,820 | 3,830 | 3,760 | 3,800 | -5 | -0.1% | 16,600 |
| 2024/06/03 | 3,805 | 3,855 | 3,785 | 3,805 | +20 | +0.5% | 14,500 |
| 2024/05/31 | 3,730 | 3,805 | 3,730 | 3,785 | +75 | +2% | 35,300 |
| 2024/05/30 | 3,650 | 3,755 | 3,640 | 3,710 | +45 | +1.2% | 28,500 |
| 2024/05/29 | 3,700 | 3,720 | 3,645 | 3,665 | -30 | -0.8% | 18,800 |
| 2024/05/28 | 3,745 | 3,755 | 3,695 | 3,695 | -50 | -1.3% | 16,900 |
| 2024/05/27 | 3,730 | 3,745 | 3,710 | 3,745 | +5 | +0.1% | 18,900 |
| 2024/05/24 | 3,780 | 3,780 | 3,725 | 3,740 | -45 | -1.2% | 15,600 |
| 2024/05/23 | 3,730 | 3,800 | 3,725 | 3,785 | +45 | +1.2% | 17,300 |
| 2024/05/22 | 3,800 | 3,800 | 3,740 | 3,740 | -45 | -1.2% | 16,900 |
| 2024/05/21 | 3,850 | 3,870 | 3,770 | 3,785 | -65 | -1.7% | 31,500 |
| 2024/05/20 | 3,880 | 3,905 | 3,840 | 3,850 | -45 | -1.2% | 30,500 |
| 2024/05/17 | 3,890 | 3,905 | 3,865 | 3,895 | +5 | +0.1% | 20,500 |
| 2024/05/16 | 3,910 | 3,925 | 3,850 | 3,890 | -15 | -0.4% | 15,600 |
| 2024/05/15 | 3,970 | 3,990 | 3,885 | 3,905 | -25 | -0.6% | 14,000 |
| 2024/05/14 | 3,970 | 4,000 | 3,920 | 3,930 | -25 | -0.6% | 18,500 |
| 2024/05/13 | 4,015 | 4,015 | 3,945 | 3,955 | -60 | -1.5% | 10,100 |
| 2024/05/10 | 4,035 | 4,080 | 4,010 | 4,015 | -20 | -0.5% | 19,400 |
| 2024/05/09 | 3,975 | 4,035 | 3,970 | 4,035 | +60 | +1.5% | 8,200 |
| 2024/05/08 | 3,950 | 4,010 | 3,950 | 3,975 | -10 | -0.3% | 22,900 |
| 2024/05/07 | 4,015 | 4,015 | 3,930 | 3,985 | +25 | +0.6% | 25,800 |
| 2024/05/02 | 3,995 | 4,035 | 3,960 | 3,960 | -15 | -0.4% | 20,600 |
| 2024/05/01 | 3,945 | 4,015 | 3,935 | 3,975 | +30 | +0.8% | 23,000 |
| 2024/04/30 | 3,850 | 4,005 | 3,785 | 3,945 | +90 | +2.3% | 82,400 |
| 2024/04/26 | 3,790 | 3,880 | 3,760 | 3,855 | +65 | +1.7% | 48,200 |
| 2024/04/25 | 3,785 | 3,830 | 3,765 | 3,790 | +30 | +0.8% | 39,500 |
| 2024/04/24 | 3,820 | 3,820 | 3,730 | 3,760 | -20 | -0.5% | 18,900 |
| 2024/04/23 | 3,800 | 3,805 | 3,755 | 3,780 | +15 | +0.4% | 14,900 |
| 2024/04/22 | 3,745 | 3,780 | 3,705 | 3,765 | +75 | +2% | 20,100 |
| 2024/04/19 | 3,765 | 3,765 | 3,645 | 3,690 | -85 | -2.3% | 22,300 |
| 2024/04/18 | 3,695 | 3,790 | 3,650 | 3,775 | +110 | +3% | 44,900 |
| 2024/04/17 | 3,780 | 3,780 | 3,655 | 3,665 | -125 | -3.3% | 40,000 |
| 2024/04/16 | 3,860 | 3,875 | 3,785 | 3,790 | -105 | -2.7% | 26,500 |
| 2024/04/15 | 3,910 | 3,935 | 3,870 | 3,895 | -55 | -1.4% | 26,400 |
| 2024/04/12 | 3,975 | 3,990 | 3,950 | 3,950 | -25 | -0.6% | 15,600 |
| 2024/04/11 | 3,990 | 4,000 | 3,935 | 3,975 | -55 | -1.4% | 32,500 |
| 2024/04/10 | 4,010 | 4,040 | 4,010 | 4,030 | +20 | +0.5% | 5,200 |
| 2024/04/09 | 4,065 | 4,065 | 3,995 | 4,010 | -40 | -1% | 18,700 |
| 2024/04/08 | 4,070 | 4,075 | 4,010 | 4,050 | +20 | +0.5% | 14,800 |
| 2024/04/05 | 4,000 | 4,050 | 3,990 | 4,030 | +5 | +0.1% | 17,900 |
| 2024/04/04 | 4,070 | 4,080 | 4,005 | 4,025 | -85 | -2.1% | 34,100 |
| 2024/04/03 | 4,045 | 4,130 | 4,030 | 4,110 | +45 | +1.1% | 57,600 |
| 2024/04/02 | 4,140 | 4,140 | 4,020 | 4,065 | -45 | -1.1% | 41,100 |
| 2024/04/01 | 4,140 | 4,160 | 4,090 | 4,110 | +15 | +0.4% | 28,000 |
| 2024/03/29 | 4,115 | 4,115 | 4,060 | 4,095 | -20 | -0.5% | 16,400 |
| 2024/03/28 | 4,125 | 4,175 | 4,080 | 4,115 | -20 | -0.5% | 20,600 |
201～
250
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
